{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:20:21Z","timestamp":1786980021598,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00345-013-1184-2","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T13:27:12Z","timestamp":1381843632000},"page":"1067-1074","source":"Crossref","is-referenced-by-count":10,"title":["Characteristics of modern Gleason 9\/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland"],"prefix":"10.1007","volume":"32","author":[{"given":"F.","family":"O\u2019Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aherne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. N.","family":"O\u2019Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,16]]},"reference":[{"key":"1184_CR1","unstructured":"http:\/\/www.ncri.ie\/pubs\/pubfiles\/AnnualReport2011.pdf"},{"key":"1184_CR2","first-page":"443","volume":"183","author":"JI Epstein","year":"2010","unstructured":"Epstein JI (2010) An update of the Gleason grading system. J Urol 183:443","journal-title":"J Urol"},{"key":"1184_CR3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.ijrobp.2008.10.027","volume":"74","author":"A Nanda","year":"2009","unstructured":"Nanda A, Chen MH, Renshaw AA et al (2009) Gleason pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials. Int J Radiat Oncol Biol Phy 74:1419","journal-title":"Int J Radiat Oncol Biol Phy"},{"key":"1184_CR4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.urology.2009.11.085","volume":"76","author":"PM Pierorazio","year":"2010","unstructured":"Pierorazio PM, Guzzo TJ, Han M et al (2010) Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology 76:715","journal-title":"Urology"},{"issue":"4","key":"1184_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/pcan.2011.15","volume":"14","author":"SM Chan","year":"2011","unstructured":"Chan SM, Garcia FJ, Chin JL et al (2011) The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer. Prostate Cancer Prostatic Dis 14(4):307\u2013312","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1184_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-5347(05)67998-0","volume":"163","author":"TJ Sebo","year":"2000","unstructured":"Sebo TJ, Bock BJ, Cheville JC et al (2000) The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 163:174\u2013178","journal-title":"J Urol"},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.2000.18.6.1164","volume":"18","author":"AV D\u2019Amico","year":"2000","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (2000) Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 18:1164\u20131172","journal-title":"J Clin Oncol"},{"key":"1184_CR8","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1097\/01.ju.0000065588.82511.06","volume":"169","author":"SJ Freedland","year":"2003","unstructured":"Freedland SJ, Aronson WJ, Terris MK et al (2003) Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol 169:2136\u20132141","journal-title":"J Urol"},{"issue":"4","key":"1184_CR9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.urology.2011.10.012","volume":"79","author":"A Chaux","year":"2012","unstructured":"Chaux A, Fajardo DA, Gonzalez-Roibon N et al (2012) High grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy. Urology 79(4):863\u2013868","journal-title":"Urology"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2012.11324.x","volume":"111","author":"JB Eifler","year":"2012","unstructured":"Eifler JB, Feng Z, Lin BM et al (2012) An updated prostate cancer staging nomogram (Partin Tables) based on cases from 2006\u20132011. BJU Int 111:22\u201329","journal-title":"BJU Int"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"JI Epstein","year":"2005","unstructured":"Epstein JI, Allsbrook WC Jr, Amin MB et al (2005) The 2005 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228\u20131242","journal-title":"Am J Surg Pathol"},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1464-410X.2008.08197.x","volume":"103","author":"H Uemura","year":"2009","unstructured":"Uemura H, Hoshino K, Sasaki T et al (2009) Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens. BJU Int 103:1190\u20131194","journal-title":"BJU Int"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2008.20.4669","volume":"27","author":"JR Stark","year":"2009","unstructured":"Stark JR, Perner S, Stampfer MJ et al (2009) Gleason score and lethal prostate cancer: does 3\u00a0+\u00a04\u00a0=\u00a04\u00a0+\u00a03? J Clin Oncol 27:3459\u20133464","journal-title":"J Clin Oncol"},{"key":"1184_CR14","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/j.ijrobp.2011.04.037","volume":"81","author":"MH Stenmark","year":"2011","unstructured":"Stenmark MH, Blas K, Halverson S et al (2011) Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease. Int J Radiat Oncol Biol Phys 81:e335\u2013e344","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1184_CR15","first-page":"1533","volume":"298","author":"AA Patel","year":"2007","unstructured":"Patel AA, Chen MH, Renshaw AA, D\u2019Amico AV (2007) PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. JAMA 298:1533\u20131538","journal-title":"JAMA"},{"key":"1184_CR16","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2011.01.063","volume":"81","author":"A Sabolch","year":"2011","unstructured":"Sabolch A, Feng FY, Daignault-Newton S et al (2011) Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. Int J Radiat Oncol Biol Phys 81:e351\u2013e360","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1184_CR17","doi-asserted-by":"crossref","unstructured":"Eifler JB, Feng Z, Lin BM et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int. (in press). doi: 10.1111\/j.1464-410X.2012.11324.x","DOI":"10.1111\/j.1464-410X.2012.11324.x"},{"issue":"5","key":"1184_CR18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","volume":"61","author":"JI Epstein","year":"2012","unstructured":"Epstein JI, Feng Z, Trock BJ et al (2012) Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol 61(5):1019\u20131024","journal-title":"Eur Urol"},{"issue":"1","key":"1184_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1464-410X.2008.08059.x","volume":"103","author":"AS Moussa","year":"2009","unstructured":"Moussa AS, Li J, Soriano M et al (2009) Prostate biopsy and clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. BJU Int 103(1):43\u201348","journal-title":"BJU Int"},{"issue":"2","key":"1184_CR20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.urology.2012.09.034","volume":"81","author":"JO DeLancey","year":"2013","unstructured":"DeLancey JO, Wood DP Jr, He C et al (2013) Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology 81(2):354\u2013357","journal-title":"Urology"},{"issue":"4","key":"1184_CR21","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.ijrobp.2011.04.048","volume":"81","author":"FY Feng","year":"2011","unstructured":"Feng FY, Qian Y, Stenmark MH et al (2011) Perineural invasion predicts increased recurrence, metastasis and death from prostate cancer following treatment with dose-escalated radiation therapy. Int J Radiat Oncol Biol Phys 81(4):e361\u2013e367","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1184_CR22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.ijrobp.2008.10.027","volume":"74","author":"A Nanda","year":"2009","unstructured":"Nanda A, Chen MH, Renshaw AA et al (2009) Gleason pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials. Int J Radiat Oncol Biol Phys 74(5):1419\u20131423","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1184_CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-410X.2009.08684.x","volume":"105","author":"DM Moreira","year":"2010","unstructured":"Moreira DM, Banez LL, Presti JC et al (2010) Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the shared equal access regional cancer hospital database. BJU Int 105(1):28\u201333","journal-title":"BJU Int"},{"issue":"4","key":"1184_CR24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.urology.2012.10.074","volume":"81","author":"A Elshafei","year":"2013","unstructured":"Elshafei A, Moussa AS, Hatem A et al (2013) Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy. Urology 81(4):826\u2013830","journal-title":"Urology"},{"issue":"5","key":"1184_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jmedgenet-2011-100290","volume":"49","author":"H Roudgari","year":"2012","unstructured":"Roudgari H, Hemminki K, Brandt A et al (2012) Prostate cancer risk assessment model: a scoring model based on the Swedish family-cancer database. J Med Genet 49(5):345\u2013352","journal-title":"J Med Genet"},{"issue":"4","key":"1184_CR26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2012.02.032","volume":"62","author":"KF Jansson","year":"2012","unstructured":"Jansson KF, Akre O, Garmo H et al (2012) Concordance of tumour differentiation among brothers with prostate cancer. Eur Urol 62(4):656\u2013661","journal-title":"Eur Urol"},{"key":"1184_CR27","unstructured":"Cancer Research UK (2011) European age-standardized rates of prostate cancer. GLOBOCAN 2008 v1.2. IARC. http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/types\/prostate\/incidence\/uk-prostate-cancer-incidence-statistics"},{"key":"1184_CR28","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.juro.2010.06.008","volume":"184","author":"B Holmstrom","year":"2010","unstructured":"Holmstrom B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Stattin P, National Prostate Cancer Registry of Sweden (2010) Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study. J Urol 184:1322\u20131327","journal-title":"J Urol"},{"key":"1184_CR29","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.juro.2011.02.009","volume":"185","author":"D O\u2019Brien","year":"2011","unstructured":"O\u2019Brien D, Loeb S, Carvalhal GF et al (2011) Delay of surgery in men with low risk prostate cancer. J Urol 185:2143\u20132147","journal-title":"J Urol"},{"issue":"3","key":"1184_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0090-4295(99)00150-8","volume":"54","author":"N Lee","year":"1999","unstructured":"Lee N, Newhouse JH, Olsson CA et al (1999) Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients. Urology 54(3):490\u2013494","journal-title":"Urology"},{"issue":"6","key":"1184_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10334-008-0116-4","volume":"21","author":"TA Masterson","year":"2008","unstructured":"Masterson TA, Touijer K (2008) The role of endorectal coil MRI in preoperative staging and decision-making for the treatment of clinically localized prostate cancer. MAGMA 21(6):371\u2013377","journal-title":"MAGMA"}],"updated-by":[{"DOI":"10.1007\/s00345-014-1249-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T00:00:00Z","timestamp":1392422400000}}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-013-1184-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1184-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T17:35:12Z","timestamp":1564508112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-013-1184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,16]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s00345-013-1184-2","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,16]]}}}